Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. - Wikidata - awgldk - TriplyDB

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

http://www.wikidata.org/entity/Q36670143

about

Human TSH receptor ligands as pharmacological probes with potential clinical application Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.A prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study.β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study.Subclinical thyroid dysfunction and incident hip fracture in older adults Vitamin C prevents hypogonadal bone loss Thyroid and bone: macrophage-derived TSH-β splice variant increases murine osteoblastogenesis.Further evidence for direct pro-resorptive actions of FSH The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures Thyroid bone disease.A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels.Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss.WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.The Glu727 Allele of Thyroid Stimulating Hormone Receptor Gene is Associated with Osteoporosis.Genome-wide Survey of Runs of Homozygosity Identifies Recessive Loci for Bone Mineral Density in Caucasian and Chinese Populations.Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton.Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease.Coordination of hypothalamic and pituitary T3 production regulates TSH expression.Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.Thyroid-stimulating hormone is significantly associated with bone health status in men.Multiple Transduction Pathways Mediate Thyrotropin Receptor Signaling in Preosteoblast-Like Cells.FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis.Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeleton Oxytocin is an anabolic bone hormone Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice.Regulation of insulin-like growth factors and their binding proteins by thyroid stimulating hormone in human osteoblast-like (SaOS2) cells.Expanding the Role of Thyroid-Stimulating Hormone in Skeletal Physiology.An Essential Physiological Role for MCT8 in Bone in Male Mice.Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro.Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH.Actions of pituitary hormones beyond traditional targets.

P2860

Q33640737-690A8D2A-F11A-40E3-879F-0DFCB9B75E60 Q33841948-BBFB150A-A363-4EAC-926B-398777FF5097 Q33893069-75A256B1-A1BA-4BAE-9F83-874C9BB8A61E Q33913233-46C9CFFE-5962-4B97-AAFE-C8F0E6219890 Q33999046-CD439DA2-FC51-4D69-B82B-97F5F7DF756A Q34004594-3202F906-5870-4387-9A53-21985B7D4200 Q34442784-20BE4898-3685-4C4C-AFCB-E1BCACC697E0 Q35021053-DA886CCE-DE0C-47ED-9054-BDDE3C385B25 Q35130784-1B7691AC-44DE-45AE-B74E-0F8F8E8F0C0E Q35140845-8E859BC2-5CA3-4A86-8DBE-176940873D22 Q35239910-C70B54DE-1C4D-48F1-8CBB-A149C398ED61 Q35838699-E12529DF-F7DF-478B-9F43-2C362997F50D Q35872216-F44DDFE8-D290-4898-AC75-1136FDC78FF6 Q36026720-728BCF73-7803-4887-82ED-4EF28EE89434 Q36034275-1313E33F-BAAF-47D8-BE92-E0BDFDBBAAE1 Q36132330-8AD2CE3F-C477-468D-B118-44A087AAD1CE Q36190818-46E04A01-54B7-4705-A3EF-2A2166D0A366 Q36217229-630089F7-C5CA-4F0F-991F-D35CFF53BB16 Q36221704-610C2015-CE90-4460-BD9A-6275CE55BCE6 Q36290316-84883865-8B82-4FE0-9271-3123C91BD447 Q36358885-D4B83ADE-4253-471C-A712-553A0295BFAF Q36733398-B0F1D6CF-99E4-4D20-BBE5-7EF24A93F6B2 Q36773018-047EA5AD-4A7C-445B-92F4-95268A260A96 Q36909820-63166520-6990-4A38-95BD-8A87CAC0DB9B Q36911644-F59FE944-ACB8-4128-8937-262292E19117 Q36931382-72A2B4B9-AE56-4540-B32B-DA82EB429C2B Q36932168-79DF691A-1A57-4DE9-8D4C-62622EF9516A Q37182727-66ED1516-EE23-4E06-AE39-038711CA5826 Q37257652-7869F350-A8E3-450C-B1CD-83F173248DED Q39335819-EC991D00-40A7-46E0-A387-7D9FE6CF7BB2 Q42372614-CABACB37-F53E-4585-84F9-0F452491ECAD Q47127976-D32276AD-FEE4-4186-A0C3-5010E96F49B4 Q47154479-51F0F6B6-6D6B-4613-8279-713F277EA9B8 Q51534118-681B37C0-B6BC-4B1B-900A-CB23CE12D7E1 Q52647974-264DDCC9-0061-4EC7-9B1C-43D01F750C05

P2860

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

http://www.wikidata.org/entity/Q36670143

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

@ast

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

@en

type

label

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

@ast

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

@en

prefLabel

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

@ast

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

@en

P1433

Q36670143-81E517F8-56E9-41FD-8C90-FFCBD5D562C8

P1476

Q36670143-9064F94B-A13E-4B99-B141-E6835503381D

P2093

Q36670143-258D7F67-2C3D-46CD-BC06-FFF9D319466E

Q36670143-2648E32C-03BD-4708-B5D4-B1C0A645BC74

Q36670143-4A395D08-1C36-4636-ADA1-7907D81B89B7

Q36670143-51488380-95C5-4E00-8E41-457FF4F46792

Q36670143-518A6C8D-7303-4365-90CD-60A6ECE8F766

Q36670143-56022DB1-7A06-4152-93D2-0996D5B9FEAD

Q36670143-6B98091D-750D-4882-AA91-B90BE736FF41

Q36670143-7C91F44D-EFE7-4628-A86C-137AC199CF3F

Q36670143-7DF9EDF0-0551-4980-9051-B2E4234A97EF

Q36670143-A1B9F372-3B7F-4E4B-8331-E3D7DF036DE2

P2860

Q36670143-06FDBC14-F074-403F-A90D-86469BB7F5DA

Q36670143-0FDBC4DB-AE83-430A-B8AE-BA64A9770561

Q36670143-1832A9FF-2F3E-4108-8737-69FA7E7AB5DF

Q36670143-2546EB54-6994-474F-80DC-E7E59B29406B

Q36670143-2734E6A3-9C5B-48CD-8803-5ADE3C7E8C6E

Q36670143-2B1E48C4-3F1D-4176-97AC-3F1E59ABB527

Q36670143-333DA298-01A1-42AB-A3C4-8DF5D0E0FC56

Q36670143-42608FB9-C79A-4638-9065-BC8A34EBA719

Q36670143-4AA2BC5E-7957-42B0-BA69-A13133E16DD9

Q36670143-579BE76F-04AE-46DD-AD05-BFDD7404D83C

P304

Q36670143-230BE45E-4B74-4650-A9CA-A518726C8D6B

P31

Q36670143-0D9C5C5D-EA9E-4567-B070-5CD9C6FE7874

P356

Q36670143-28750004-BAF5-4085-8054-9AB82B91597A

P407

Q36670143-CE63E5A7-D786-49B4-9F78-9B52A6928D94

P433

Q36670143-422D7743-BBCE-4D29-82BC-CB259A44AA6E

P478

Q36670143-3CE870A0-247D-412E-B57A-58046DCC3B58

P50

Q36670143-F41EB333-88AF-4C2A-A507-C22D4F0BD0DD

P577

Q36670143-5CF4534F-85A1-4E90-8B64-035322CD4A00

P5875

Q36670143-63882164-6487-4075-8DDF-9214259FAB1A

P698

Q36670143-060A2BCF-1103-44B6-AAE3-12EE0A43D07A

P932

Q36670143-B4C3EB73-49CA-4ED0-B52A-728B7CE102CF

P356

PNAS.0712395105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.

@en

P2093

Ario Arabi

http://www.w3.org/2001/XMLSchema#string

Arjun Natrajan

http://www.w3.org/2001/XMLSchema#string

Baljit S Moonga

http://www.w3.org/2001/XMLSchema#string

Etsuko Abe

http://www.w3.org/2001/XMLSchema#string

Guozhe Yang

http://www.w3.org/2001/XMLSchema#string

Itai Bab

http://www.w3.org/2001/XMLSchema#string

Jameel Iqbal

http://www.w3.org/2001/XMLSchema#string

John McPherson

http://www.w3.org/2001/XMLSchema#string

Kosj Yamoah

http://www.w3.org/2001/XMLSchema#string

Kuber Sampath

http://www.w3.org/2001/XMLSchema#string

P2860

FSH directly regulates bone mass

The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding

The effect of thyroid hormone on skeletal integrity.

Subclinical thyrotoxicosis and the heart.

TNFalpha mediates the skeletal effects of thyroid-stimulating hormone

Direct stimulation of bone resorption by thyroid hormones

Subclinical hyperthyroidism: clinical features and treatment options.

A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism.

TSH and bone loss.

Update in osteoporosis and metabolic bone disorders.

P304

4289-4294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0712395105

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5520670

http://www.w3.org/2001/XMLSchema#string

P698

18332426

http://www.w3.org/2001/XMLSchema#string

P932

2393772

http://www.w3.org/2001/XMLSchema#string